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doi:10.1016/j.jtcvs.2007.04.003bjective: The aim of the study was to evaluate the safety and efficacy of an
utologous surgical tissue adhesive.
ethods: Autologous glue was made out of canine concentrated plasma proteins
ixed with 7.5% glutaraldehyde. Tensile strength and cytotoxicity of the autologous
lue were tested. In a dog model, 8 transectioned iliac arteries were reanastomosed
y using the animal’s glue as the sole fixation method. After 120 days, all animals
ere angiographically controlled for patency and killed for histologic and immu-
ohistochemical examination of the anastomosis.
esults: The autologous glue showed sufficient tensile strength (557 135 N/mm2).
he elasticity of the glue is influenced by variations of concentrations in both
roteins and glutaraldehyde. Glutaraldehyde remained cytotoxic, even at low con-
entrations of 2.5%. All operative procedures were successful. Angiographs per-
ormed before animal death showed all but 1 vessel to be patent and showed
anifest compression signs in 3 anastomoses. Histological examination revealed
nly a foreign-body reaction adjacent to the surface of the glue. The autologous glue
oes not trigger any immune response on immunochemistry. Because fibroblastic
eo-endothelial lining was near to normal, potential glutaraldehyde leaching does not
eem too harmful for the vascular juncture in the dog model.
onclusions: Autologous glutaraldehyde glue has been used successfully as a
ascular adhesive. In contrast to our previous studies with heterologous glue, we did
ot find a fierce acute inflammatory reaction indicating immune triggering. Never-
heless, glutaraldehyde remains a cytotoxic cross-linker. It is yet not known whether
utologous glutaraldehyde glue can be used safely in clinical practice.
lthough manual suturing remains the gold standard, the quest for alternative
methods to create the perfect vascular juncture is still ongoing. In the past,
various types of glue have been used to secure an anastomosis, with diverse
esults. Most of the initial research on glues was focused on sealants to seal off
iquid or gas leaks. Several studies demonstrated the efficacy of fibrin sealants in
ifferent types of operations.1 This first generation of sealants used bovine com
ents in part. The immune response to bovine components can lead to severe
naphylactic reactions when the patient is re-exposed to the product.2 In addition to
brin sealants, other types of glue have been used. Initially, cyanoacrylic glues
howed good tensile strength but caused deterioration of the vascular wall.3 On the
ther hand, because of their good mechanical profile component, protein-aldehyde
lues are frequently used for vascular repair in clinical practice. The utility of the
-component gelatin-resorcinol-formaldehyde (GRF) glue (Cardial Technopole, St
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ETtienne, France) as adjuvant treatment in aortic dissection
as already obvious in the 1970s.4 We previously demon-
trated the feasibility of coronary anastomoses using Bio-
lue, which is composed of bovine serum albumin (45%
olution) and glutaraldehyde (10% solution; CryoLife Inc,
ennesaw, Ga) as the sole adhesive with acceptable re-
ults.5 The major disadvantages of these polymerized co-
onent glues are their stiffness and potential toxicity and the
act that some components come from another species than
he acceptor, which can trigger immune reactions. To cope
ith the latter and to comply with the European directive
tarting January 2007 to ban the use of bovine products, the
earch for autologous adhesives is on. We were particularly
nterested in the immunohistologic host reaction using a
-component autologous protein glue as adhesive. This article
escribes the results of the use of a cross-linked protein
ubstrate as a surgical tool to perform sutureless vascular
nastomoses in an experimental dog model.
aterials and Methods
abrication of the Glue
n the dog model 75 mL of blood was drawn through a vein
uncture into a syringe containing 6 mL of citrate (Baxter, Brus-
els, Belgium) from each animal before the start of the surgical
rocedure. After centrifugation, approximately 30 to 45 mL of
lasma was obtained, and consequently, all cells were retransfused
o the animal.
Our 2-component autologous glue was made by mixing a
efined plasma concentrate with 7.5% glutaraldehyde (VWR In-
ernational, Leuven, Belgium). Previous in vitro testing revealed
hat a 4-fold protein concentration from average baseline is the
deal substrate for the making of a firm but elastic glue indepen-
ent of the species (human, bovine, or canine) (De Somer et al,
007, unpublished data). Also, the glutaraldehyde concentration
2.5%–15%) linearly predicts the speed of the polymerization
from several minutes up to a few seconds). Ten to 15 mL of
anine plasma was ultracentrifuged for 60 minutes at 3800g in an
micon Ultra-15 filter unit (Millipore Corp, Billerica, Mass) to
btain the exact protein content of the plasma concentrate. The
reconcentration and postconcentration values of albumin were
etermined by using a modular machine (Roche, Brussels, Bel-
ium), and fibrinogen concentrations were analyzed on an STA-R
evice (Roche, Brussels, Belgium; Table 1). Once the ideal concen
ration of at least 100 g/L albumin and 5 g/L fibrinogen is reached,
Abbreviations and Acronyms
GRF gelatin-resorcinol-formaldehyde
MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymeth-
oxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium,
inner salt]
PBS  phosphate-buffered saline
TIMI Thrombolysis In Myocardial Infarctionhe concentrate and 7.5% glutaraldehyde are loaded in a Mixpac c
16 The Journal of Thoracic and Cardiovascular Surgery ● Auguixing device (Mixpac, Rotkreuz, Switzerland). After careful
eairing, a small mixing tip is mounted on top of the cartridge, and
he sample is applied. Full holding power is achieved within 90
econds.
ensile Strength
ensile strength was evaluated with the “Pull to Break” test
rogram of a Lloyd LF Plus digital testing machine (Analis,
uarlée, Belgium). Two milliliters of glue was applied on 2 alu-
inum blocks. Three minutes after application, the blocks were
oaded on the Lloyd LF Plus holders and separated at a pulling
peed of 10 mm/min. Tissucol Duo (Tisseel; Baxter, Brussels,
elgium) and BioGlue were also tested.
lasticity Testing
he elasticity of BioGlue and autologous canine glue was tested
ith a Loyd LF Plus universal material tester (Analis). The
uild-in “Push to Maximum Load” test program was used for the
nalysis. Two milliliters of glue was applied in a plastic vial.
wenty minutes after application, a metal rod with a diameter of
5.9 mm was placed on top of the glue and pushed 3 mm into the
lue at a rate of 1 mm/min.
ytotoxicity Study
he source of plasma used in this experiment is canine. The test
amples were allowed to polymerize about 15 minutes before the
ell-culture experiment. The samples were not really sterilized.
he plasma concentrate was handled with sterile material. The
lutaraldehyde solutions were filtered with a sterile filter unit
Millex, 33 mm; Millipore, Billerica, Mass). The mixing of the
lasma and glutaraldehyde was performed with sterile material.
ll steps were carried out in a sterile laminar flow cabinet with
terile material. The same type of glue was used to fix the samples
o the bottom of each well. The glue was allowed to set about 15
inutes before adding the cells. The compatibility of each test
ample was evaluated by using an in vitro cell-culture assay. The
ells used in the cytotoxicity study were chicken embryo fibro-
lasts. The cells were cultured in 75-cm2 tissue-culture flasks
Cellstar; Greiner Bio-One, Wemmel, Belgium) in Dulbecco’s
odified Eagle’s medium (Gibco, Invitrogen, Merelbeke, Bel-
ium) supplemented with 10% fetal calf serum (Gibco, Invitro-
en). The cell culture was maintained in a humidified incubator at
7°C at 5% CO2 in air. In the cell-culture assay 16-mm-diameter
pecimens cut from each sterile test sample were glued on the
ottom of each well in a 24-well plate (Cellstar, Greiner Bio-One,
elgium; the diameter of each well is about 16 mm). Subse-
uently, chicken embryo fibroblasts at 4  104 cells per well were
eeded evenly on the test specimens in 200 L of Dulbecco’s
odified Eagle’s medium supplemented with 10% FCS. The cell
ABLE 1. Protein content of the canine concentrate (n 3)
Plasma 60-min sample
lbumin 29.5  3.3 g/L 146.5 33.3g/L
ibrinogen 1.55  0.38g/L 8.08 2.91g/Lulture was maintained in a humidified incubator at 37°C with 5%
st 2007
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ETO2 in air. Therefore the test material was placed in direct contact
ith the cell layer for 24 and 48 hours. By using the [3-(4,5-
imethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophe-
yl)-2H-tetrazolium, inner salt] (MTS) assay (Promega, Madison,
is), the viable cells cultured on each test specimen were determined
4 to 48 hours after cell seeding. The cells cultured on each test
pecimen were washed with phosphate-buffered saline (PBS) twice,
nd viable cell numbers then were determined indirectly by the
onversion of MTS into a soluble dye. The MTS assay is based on
he conversion of MTS into aqueous soluble formazan by mitochon-
rial dehydrogenase enzymes found in metabolically active cells. The
uantity of formazan product, as measured by the amount of 490-nm
bsorbance, is directly proportional to the number of living cells in
ulture. In the test 100 L of MTS solution was added to the culture
ells. After 4 hours at 37°C in a humidified 5% CO2 atmosphere, the
bsorbance at 490 nm was recorded by using an ELISA plate reader
EL 800, Universal Microplate Reader; Bio-Tek, Winooski, Vt).
nimal Model
our mongrel dogs had both their external iliac arteries repaired by
eans of gluing after total surgical section of the arteries. Average
ge of the exbreeder female dogs was 8.9 years (7.5–11.2 years),
nd average weight was 13.4 kg (10–17 kg). No vaccines that had
een in contact with bovine albumin were previously administered
o the animals. The dogs fasted for 24 hours and were premedi-
ated. Once the animal was positioned in the supine position, a
eripheral intravenous line was placed in the left upper limb.
ifteen milligrams per kilogram of cephalosporin was injected
ntramuscularly for antibiotic prophylaxis, and intravenous crys-
alloid fluids were given for maintenance. A 3-lead electrocardio-
ram was used to monitor heart rate and rhythm. Propofol, 0.5
g/kg (Diprivan 2% Emulsion; AstraZeneca, Ghent, Belgium),
as administrated before tracheal intubation. Ventilation parame-
ers were adjusted to keep the blood gas values within normal
ange. Anesthesia was maintained by using intravenous propofol,
to 8 mg · kg1 · h1; fentanyl, 1 g/kg (Janssen Pharmaceu-
ica, Beerse, Belgium); and pancurorium, 0.1 mg/kg, for muscle
elaxation. Incisions were made in both groins to expose the iliac
rteries. Arteries were dissected and snared. One milligram per
ilogram of heparin was administered, and the iliac arteries were
lamped before complete transection. Both ends were fixed with
wo 7-0 monofilament extravascular stitches to avoid retraction.
onsequently, both ends were slid over a 5-mm balloon catheter
ntroduced 2 cm more distally by direct puncture. The margins
ere manually positioned end to end after balloon inflation. Two
illiliters of autologous canine glue was applied and dried for 2
inutes. The distal elastic snares were removed, and the anasto-
osis was opened after 5 minutes. After hemostatic control, the
ncision was closed in layers with insertion of a small drain. After
xtubation, the dogs were kept in the recovery room for 4 hours.
are was taken for catheters and the drain, which were progres-
ively removed. Once daily, cephalosporin was administered in-
ramuscularly. Analgesics were given as necessary. After 4 hours
nd after all medication had been given, the animal was returned
o a controlled animal facility, where the general health of the dog
as checked daily. The Ethical Committee for Animal Experimen-ation of the University of Ghent approved all procedures (Protocol 2
The Journal of Thoracic3/21). All animals received care in conformation with interna-
ional and Belgian legislation.6
ngiographic Analysis
mmediately postoperatively and at 120 days (before death), an-
iographic analysis was performed after achievement of general
nesthesia.
ight Microscopic Analysis
he anastomotic site was longitudinally transected, and samples
or histologic analysis were fixed in 4% phosphate-buffered form-
ldehyde and embedded in paraffin. Tissues were cut at 5-m
ections and mounted on poly-L-lysine–coated slides. Hematoxy-
in and eosin staining was performed for routine histologic eval-
ation, Masson trichrome staining for collagen, Orcin staining for
lastin, and myeloperoxidase staining for granulocytes. Monoclo-
al antibodies (with cross-reactivity to canine origin) were used to
etect macrophages (MAC-1; Serotec, Oxford, United Kingdom).
ltrathin sections (60 nm) of the anastomosis were prepared for
xamination with a Zeiss EM 900 transmission electron micro-
cope. Tissue specimens were embedded in Epon (Hexion Spe-
ialty Chemicals, Houston, Tex) and stained with uranylacetate
nd lead citrate.
mmunohistochemical Analysis
mmunohistochemical analysis was performed to detect helper/
nducer T cells (CD4; Novocastra, Newcastle upon Tyne, United
ingdom; dilution 1:20), suppressor/cytotoxic T cells (CD8; No-
ocastra; dilution 1:20), and macrophages (CD68; Dakocytoma-
ion, Glostrup, Denmark; dilution 1:2000). Five-micrometer-thick
araffin sections were fixed in formaldehyde, blocked with normal
orse serum, and incubated with unlabeled primary antibodies at
oom temperature followed by PBS washing and then incubated
ith biotinylated secondary antibodies at room temperature. Pri-
ary antibodies included mouse anti-CD4, mouse anti-CD8, and
ouse anti-human CD68 antibody. The sections were blocked
ith peroxidase solution followed by PBS washing and incubated
ith biotinylated horse anti-mouse IgG at room temperature
Vector Laboratories, Burlingame, Calif; dilution 1:500). After
ewashing with PBS, sections were incubated with horseradish
eroxidase–avidin– biotin complex solutions at 1:500 dilution
Vector Laboratories). Specific antibody binding was detected with
,3=-diaminobenzidine and counterstained with hematoxylin.
tatistical Analysis
tatistical analysis was performed with SPSS 12.0 (SPSS Inc,
hicago, Ill). Analysis of variance was performed with the post-
oc Bonferroni correction to establish differences between groups.
esults
ensile Strength
he start values of fibrinogen and albumin in the canine
lasma were 1.27 and 32.5 g/L, respectively. After 60
inutes of centrifugation in the Amicon ultrafilter, fibrino-
en and albumin concentrations increase to 8.78 and 144.4
/L, respectively. Mixing of this protein concentrate with
.5%, 5%, and 7.5% glutaraldehyde (n 3 each) resulted in
and Cardiovascular Surgery ● Volume 134, Number 2 417
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ETrespective load of 300  54, 385  52, and 557  135 N.
he maximum load for Tissucol Duo and BioGlue was 11 
and 686 120 N, respectively. Tensile strength was equal
or the 7.5% glutaraldehyde autologous glue (n  3) and
ioGlue (n  3, P  .23) but inadequate for Tisseel (n  3,
 .001). The values for tensile strength at maximum load
re converted into stress at maximum load (Newtons per
quare millimeter). The conversion gives a stress at maxi-
um load for autologous glue made from canine proteins of
.17 N/mm2. Both glutaraldehyde glues can by 10-fold
esist the strength exercised of a systolic arterial pressure at
50 mm Hg (0.016 N/mm2, Figure 1).
lasticity Testing
ioGlue analysis (n 5) revealed a mean maximum load of
22 104 N and a work to limit of 0.4 0.1 J, whereas the
anine autologous glue (n  6) showed much lower values
f 144  66 N (P  .002) for maximum load and 0.2  0.1
for work to limit (P  .001).
perative Procedures
irect sutureless reanastomosis with autologous glue was
erformed in all 8 external iliac arteries (Figure 2). O
L of autologous surgical tissue adhesive was used to
ecure the end-to-end anastomosis in our canine model. On
occasions, we used more than 2 mL of glue. In dog
umber 1 (right side) some extra glue was applied to stop
he anastomotic oozing without reclamping the artery. In
og number 3 (right side) the liquid only slowly polymer-
zed and never achieved full holding power. Because of
ncessant bleeding, we reclamped the vessel. This particular
og had very low preoperative albumin (12.7 g/L) and low
brinogen (0.149 g/L) levels. We suspected an overly low
lbumin concentrate (which was measured afterward at 46.8
Figure 1. Tensile strength test results./L), and therefore we centrifuged the plasma proteins for T
18 The Journal of Thoracic and Cardiovascular Surgery ● Augu2
nother 30 minutes (to a final concentration of 78.9 g/L of
lbumin). An extra of 2 mL of the more concentrated glue
as prepared. The second application was successful. Also,
n the same animal at the left side, we applied more than 2
L of the concentrated 90-minute glue. Average temporary
rterial occlusion time was recorded at 6.2  2.0 minutes.
ll animals survived the initial procedure. One animal pre-
ented with an important hematoma in the left groin on the
rst operative day (dog number 1, right side). No signs of
eg ischemia were recorded.
ngiographic Analysis
ll survivors underwent an angiographic scan immediately
fter the operative procedure. Flow was assessed according
o the Thrombolysis In Myocardial Infarction (TIMI) pro-
ocol for coronary arteries.7 All anastomoses were paten
mmediately postoperatively. Perfect runoff of the iliac ar-
ery (TIMI flow 3) without signs of distal alteration of the
irculation was recorded in 6 vessels. Two animals pre-
ented with clear tapering at the anastomotic site. Also,
efore death, all animals had a second angiography. Perfect
unoff of the iliac artery (TIMI flow 3) without signs of
istal alteration of the circulation was recorded in 4 vessels.
ne vessel was totally occluded (dog number 3, right side).
wo vessels presented with vascular string formation at the
nastomotic site, and 1 (dog number 1, right side) presented
ith a clear sandglass sign with impaired visualization of
he distal vascular bed (Figure 3). No additional colla
ow was observed distal to the anastomoses. Table 2 
entrates the operative and angiographic data with the mac-
oscopic findings and grading of the inflammatory response
t the anastomotic sites of all the animals.
istologic and Immunohistochemical Analysis
light microscopic scan showed a mild chronic inflamma-
ory reaction around the islets of glue, with infiltration of
ery few lymphocytes and plasma cells. The glue material
as surrounded by a chronic inflammatory perimeter con-
isting of mainly macrophages and some fibroblastic cells.
igure 2. Operative view of canine iliac artery anastomosis be-
ore death.he absence of CD4 TH lymphocytes indicates the ab-
st 2007
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ETence of antigen presentation (Figure 4). CD8 stain
hows similar findings as with an anti-CD4 immunohisto-
hemistry. Again, the absence of CD8 killer T lympho-
ytes supports the hypothesis of a negligible immune re-
ponse (Figure 5). The glue is surrounded by a perimeter
ense layers of macrophages (palisade formation) adjacent to
he intact surface of the glue and some fibroblasts (Figure
harp delineation exists between these macrophages and the
lue deposit (CD68). Rarely, a macrophage invading the
lue deposit can be noted. Some remnants of the glue are
igested by macrophages and giant cells. The highest den-
ity of macrophages was counted in the lamina elastica
xterna, acting as a filter for the migrating macrophages.
round older and more fragmented islets, a foreign-body
eaction appeared with giant cell formation. A new endo-
helial lining (CD4) was already present in most of the cases
t the site of the vascular junction. Also, few infiltrations of
lastin fibers (Orcin) of the vessel wall into the intima were
oticed. The chronic inflammatory reaction is mild com-
ared with the fierce acute inflammation we found in
revious testing with BioGlue or heterologous glue (myelo-
eroxidase). Severe infiltration of nonmacrophages (pre-
ominantly lymphocytes and some granulocytes) was only
resent in the 2 anastomoses with marked postoperative
leeding (dogs number 1 and 3, right side). Electron micro-
copic scanning confirmed the predominant foreign-body
eaction and the absence of active granulocytes.
oxicity Test
oxicity became clearly more important for increasing con-
entrations of glutaraldehyde. Even the lowest dose of 2.5%
lutaraldehyde showed a distinct cytotoxicity after 24 hours
f exposure compared with control values (Figure 7).
iscussion
n the past, several types of glue have been used to secure
igure 3. Angiographic control of the iliac anastomosis. Note the
arrowing of the vessel caused by mechanical compression
arked by a hemoclip on top.vascular anastomosis, with various results. Earlier at- m
The Journal of Thoracicigure 4. CD4. Glue material surrounded by a chronic inflamma-
ory perimeter consisting of mainly macrophages and fibroblastic
ells is shown. Note the absence of CD4 lymphocytes indicating
o antigen presentation. (Original magnification 400.)A
igure 5. CD8. This illustration shows more or less similar find-
ngs as with an anti-CD4 immunohistochemical scan. Note again
he absence of CD8 killer T lymphocytes. (Original magnification
00.)igure 6. Palisade formation of macrophages is shown. Together
ith the sharp border between the mild inflammation and the
lue deposits and the relative absence of granulocytes, these
ndings support the hypothesis that this type of glue only triggers
foreign-body reaction. (Hematoxylin and eosin staining, original
agnification 400.)
and Cardiovascular Surgery ● Volume 134, Number 2 419
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ETFigure 7. Direct contact test. The values a, b, and c mean that the experiments were performed in triplicate. a, b,
and c, Absorbance values at 490 nm by means of enzyme-linked immunosorbent assay (optical density). % Viability
a  Absorbance a / Absorbance control  100 ; % Viability b  Absorbance b / Absorbance control  100 ; and
% Viability c  Absorbance c / Absorbance control  100 . Mean  % viability a  b  c / 3. St Dev, StandardABLE 2. Operative outcome, angiographic data, and inflammatory response
Bleeding Hematoma
TIMI,
postoperative
TIMI,
120 d Macro findings
Inflammation:
macrophages
Inflammation:
nonmacrophages
og 1, left 3 3  
og 1, right   2 1 Glue   *
og 2, left 3 2  
og 2, right 3 3  
og 3, left 3 2 Glue   
og 3, right  2 0 Glue   *
og 4, left 3 3  
og 4, right 3 3  
IMI, Thrombolysis In Myocardial Infarction. TIMI flow: 3, unobstructed; 2, mild stenosis; 1, severe obstruction; 0, occluded. Glue , An excess of glue
as used. Inflammatory response: , severe; , moderate; , mild.deviation.
20 The Journal of Thoracic and Cardiovascular Surgery ● August 2007
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ETempts with nonsutured vascular anastomoses showed an
xcessive rate of suture-line disruption. Fibrin glue does not
old sufficient tensile strength and cannot be used as a
ascular adhesive.8 This was confirmed by means of 
urst-testing results. Initially, cyanoacrylic glues held good
ensile strength but caused necrosis and deterioration of the
ascular wall and aneurysm formation.3 Glubran 2 (n-butyl
-cyanoacrylate), a new promising synthetic adhesive, dis-
lays better mechanical properties regarding elasticity and
dherence than previously available cyanoacrylate products
n the rat model.9 However, one has to bear in mind 
olymerization of cyanoacrylate is an exothermic reaction.
his could lead to thermal injury in vascular applications.
ecently, 2-octylcyanoacrylate proved to be an effective
uture-line sealant of polytetrafluoroethylene conduits with
inor tissue reactivity in the sheep model.10 A preliminary
linical study of this new absorbable cyanoacrylate showed
romising results in a model of arteriovenous polytetrafluo-
oethylene shunts for dialysis access.11 However, in both
tudies the adhesive is used as a sealant and not to secure the
ntire anastomosis. Although component protein-aldehyde
dhesives definitively show sufficient tensile strength, their
ajor disadvantages are stiffness, immunogenicity, and
oxicity.
echanical Properties
RF is a hard glue and can cause mechanical compression
nd induce irreparable damage, as reported by Martinelli
nd coworkers.12 Also, its mechanical properties vary a 
epending on the amount of (often unevenly dispersed)
ighly concentrated formaldehyde. BioGlue is also a very
igid glue. Polymerized bovine albumin forms a stiff layer
nd binds firmly to the adjacent tissue. This can cause
ubstantial mechanical problems. In our clinical practice, a
7-year-old man with an ascending aortic aneurysm had a
ight myocardial infarction and consequent heart failure
ecause of mechanical compression of the reimplanted right
oronary artery caused by remnants of BioGlue in a Bentall
rocedure.
In general, 2 to 5 mL of autologous glue is sufficient
or surgical repair in small vessels. This would equal a
lood volume, before centrifugation and based on a he-
atocrit value of 40%, of 60 to 75 mL. The blood can be
ithdrawn after induction of anesthesia. Cells are then
eparated from the plasma by means of a quick centrif-
gation spin of 10 minutes. Subsequently, the plasma is
ransferred into the ultrafilter cartridges and centrifuged
or 60 minutes. After centrifugation, cells are retrans-
used to the donor. An alternate approach is the use of a
ell saver for obtaining the plasma. For extensive surgical
ntervention, blood is often withdrawn from the patient
fter induction and separated into plasma, red cells, and
latelets. Based on the example above, one would need c
The Journal of Thoracicpproximately 36 to 40 mL of the plasma. Although
ependent on the exact protein concentrations, mixing
ith 7.5% of glutaraldehyde yielded the best mechanical
esults. The glue based on canine plasma has a slightly
ower tensile strength compared with that of the commer-
ially available BioGlue. To understand whether these
ower values have a clinical relevance, the values for
ensile strength at maximum load were converted into
tress at maximum load because this represents force per
rea. The conversion gives a stress at maximum load for
utologous glue made of canine proteins of 0.17 N/mm2.
his value is 6 times higher than the stress at maximum
oad (0.027 N/mm2) obtained at a systolic blood pressure
f 200 mm Hg, which makes the glue safe for surgical
se. Although our autologous glue is definitively more
lastic than GRF or BioGlue, it still can cause mechanical
ompression. At death, we found 1 occluded vessel and 3
ented anastomoses in our dog series. In all but 1 dog, an
xcess of glue was used. In our previous work, we were
lso able to validate the magnitude of the 2 different
omponents in the final polymerization. Our experiments
emonstrate that increasing glutaraldehyde concentra-
ions mainly amplify the polymerization process. High
lbumin, but especially high fibrinogen, concentrations
ead to extreme short polymerization times but still-
lastic glue at normal glutaraldehyde concentrations (De
omer et al, 2007, unpublished data). One reason why the
utologous variant is more elastic than that of commer-
ially available glues might be the fact that apart from
lbumin, fibrinogen and other plasma proteins also re-
ain present in the glue. Opposite to most proteins that
ave a round structure, fibrinogen has a rod-like struc-
ure. This could explain the elasticity. Nevertheless, it is
lear from our experiments that the glue can cause dent-
ng of a vessel by means of external compression. There-
ore the use of excessive product for whatever reason is
ertainly a matter of great concern in smaller-sized
rteries.
mmunogenicity
he fact that some components come from another species
han the acceptor might trigger immune reactions. Although
ts tissue toxicity is of great concern, the good thing about
ormaldehyde used in high concentration (37%) is that it
uppresses all immune reactions from the porcine gelatin.
herefore fully applied GRF glue is considered by the host
s a foreign body with little inflammatory response.13 Bio-
lue is a surgical adhesive that combines 45% concentrated
ovine albumin and 10% glutaraldehyde. We already dem-
nstrated the feasibility of coronary and vascular anastomo-
es by using BioGlue as the sole adhesive with an accept-
ble short-term patency in the dog model.5,14 However,
ontrary to initial work by Gundry and associates15 and
and Cardiovascular Surgery ● Volume 134, Number 2 421
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4
ETewitt and colleagues16 in the herbivore model (go
nd sheep), we detected a strong inflammatory response and
mmunogenicity to the bovine glue in the dog model. In our
anine study the bovine glue was broken down by enzymes
eaching out of active granulocytes.14 Likewise, LeMaire
nd coworkers17 found adverse reactions, such as fibro
nd strictures of vascular anastomoses, to the glue in piglets,
lthough it is still unknown whether the same reaction might
ccur in children. Bovine serum albumin can act as an
llergen. Fiocchi and colleagues18 reported that all childre
ith beef allergy reacted to bovine albumin in a skin prick
est. The fact that albumins from animals, which are 97%
imilar in structure, sequence, and function to human albu-
in, are recognized by the human immune system as aller-
ens is remarkable. Glutaraldehyde 10% (contrary to high
oses of formaldehyde) does not entirely eliminate the
mmunogenicity. This might lead to the conclusion that
mmune reactions to the bovine glue could be quite differ-
nt, depending on the animal model used. The reaction of
erbivore animals (sheep and goat) to bovine glue is much
ore attenuated or even absent compared with that of
mni(carni)vores that have previously been in contact with
eef albumin (dog and pig). In juvenile animals and omni-
ores (pig and dog), the onset of the inflammatory response
s early and important. The human species is predominantly
mnivorous. The Mayo Clinic group found at reoperation a
erce focal acute and chronic inflammatory reaction around
slets of the glue in a patient operated on 2 years previously
or aortic dissection.19 BioGlue can act as an allergen
uman subjects and carries the potential to sensitize patients
o bovine products. Moreover, this effect could potentially
anifest itself only upon subsequent antigenic contact. Be-
ause the autologous glue comprises only proteins from the
cceptor, it avoids antibody formation, as shown in our
mmunohistologic results. Together with the sharp border
etween the mild inflammatory reaction and the glue de-
osits, the relative absence of granulocytes supports the
ypothesis that this type of glue only triggers a foreign-body
eaction.
oxicity
n many centers the use of gelatin-resorcinol-formalde-
yde glue as a sealant was abandoned because of a high
edissection rate and false aneurysm formation in aortic
issection repair attributed to necrosis.20,21 Also, high
oses of formaldehyde have a distinct toxic effect on
eural tissue. Although excellent results with BioGlue in
ases of acute proximal aortic dissection have been
chieved, it is not without complications. Several authors
ave reported problems of necrosis and aneurysm forma-
ion with Bioglue similar to the GRF toxicity.22,23 Carrel
nd colleagues24 were the first to report that fragments
he adhesives might embolize. This has been confirmed
22 The Journal of Thoracic and Cardiovascular Surgery ● Auguy the interesting experimental work of LeMaire and
oworkers.25 They demonstrated that the glue might g
ccess to the vessel lumen through suture-line needle
oles (10% of the cases in the pig model). On the other
and, Hewitt and associates16 reported, apart from en-
ouraging experimental work, preliminary results of min-
mal reactions in human subjects 2 and 9 months after
cute type A ascending aortic repair operations with
ioglue. Although aortic tissue could be less sensitive to
he toxic effects of the glutaraldehyde, minor lesions
aused by the glue might still involve a certain risk for
ubsequent complications in human subjects. We believe
hat the autologous variant offers several biologic advan-
ages, with the absence of immune response for a start.
lso, the fact that the autologous glue contains fibrinogen
ight be beneficial for healing. Finally, the lowered
lutaraldehyde concentration will make the glue less
oxic and will reduce the amount of glutaraldehyde leach-
ng toward the surrounding tissues. Nevertheless, glutar-
ldehyde remains cytotoxic, even at low concentrations
f 2.5%. A nontoxic cross-linker would be more appro-
riate, provided it has a limited polymerization time for
asy clinical use.
imitations of the Study
his is a preliminary experimental study. Although autolo-
ous glue is more elastic than other commercially available
rotein-aldehyde adhesives, it still can cause external com-
ression of the vessel. Another major problem is that poly-
erization time (dependent on the glutaraldehyde concen-
ration) is to be kept between 1 and 2 minutes for practical
se. Although we solved the immunogenicity problem by
sing exclusively autologous proteins, the fact that we were
ot able to replace toxic glutaraldehyde as a cross-linker
emains in our eyes a serious drawback to free use of the
dhesive in a clinical setting. Before autologous glue can be
onsidered a true biocompatible medical device, the exact
adverse) effects of the glue on human tissue remain to be
nvestigated.
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